{
    "title": "PR-NET: Leveraging Pathway Refined Network Structures for Prostate Cancer Patient Condition Prediction",
    "abstract": "arXiv:2403.05818v1 Announce Type: new  Abstract: Motivation: The diagnosis and monitoring of Castrate Resistant Prostate Cancer (CRPC) are crucial for cancer patients, but the current models (such as P-NET) have limitations in terms of parameter count, generalization, and cost. Results: To address the above issues, we develop a more accurate and efficient Prostate Cancer patient condition prediction model, named PR-NET. By compressing and optimizing the network structure of P-NET, the model complexity is reduced while maintaining high accuracy and interpretability. The PR-NET demonstrated superior performance in predicting prostate cancer patient outcomes, outshining P-NET and six other traditional models with a significant margin. In our rigorous evaluation, PR-NET not only achieved impressive average AUC and Recall scores of 0.94 and 0.83, respectively, on known data but also maintained robust generalizability on five unknown datasets with a higher average AUC of 0.73 and Recall of 0",
    "link": "https://arxiv.org/abs/2403.05818",
    "context": "Title: PR-NET: Leveraging Pathway Refined Network Structures for Prostate Cancer Patient Condition Prediction\nAbstract: arXiv:2403.05818v1 Announce Type: new  Abstract: Motivation: The diagnosis and monitoring of Castrate Resistant Prostate Cancer (CRPC) are crucial for cancer patients, but the current models (such as P-NET) have limitations in terms of parameter count, generalization, and cost. Results: To address the above issues, we develop a more accurate and efficient Prostate Cancer patient condition prediction model, named PR-NET. By compressing and optimizing the network structure of P-NET, the model complexity is reduced while maintaining high accuracy and interpretability. The PR-NET demonstrated superior performance in predicting prostate cancer patient outcomes, outshining P-NET and six other traditional models with a significant margin. In our rigorous evaluation, PR-NET not only achieved impressive average AUC and Recall scores of 0.94 and 0.83, respectively, on known data but also maintained robust generalizability on five unknown datasets with a higher average AUC of 0.73 and Recall of 0",
    "path": "papers/24/03/2403.05818.json",
    "total_tokens": 931,
    "translated_title": "PR-NET：利用精细化通路网络结构进行前列腺癌患者状况预测",
    "translated_abstract": "动机：诊断和监测去势抵抗性前列腺癌（CRPC）对癌症患者至关重要，但目前的模型（如P-NET）在参数数量、泛化能力和成本方面存在局限性。结果：为解决上述问题，我们开发了一种更准确高效的前列腺癌患者状况预测模型，名为PR-NET。通过压缩和优化P-NET的网络结构，降低了模型复杂性，同时保持了高准确性和可解释性。PR-NET在预测前列腺癌患者结果方面表现出色，超过了P-NET和其他六种传统模型显著。在我们的严格评估中，PR-NET不仅在已知数据上取得了令人印象深刻的平均AUC和召回率分数（分别为0.94和0.83），而且在五个未知数据集上保持了强大的泛化能力，平均AUC为0.73，召回率为0",
    "tldr": "PR-NET模型通过压缩和优化P-NET的网络结构，降低了模型复杂性，同时保持高准确性和可解释性，在前列腺癌患者状况预测中表现出优越性能。",
    "en_tdlr": "The PR-NET model reduces model complexity while maintaining high accuracy and interpretability by compressing and optimizing the network structure of P-NET, demonstrating superior performance in predicting prostate cancer patient outcomes."
}